Safe Harbor Fiduciary’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Safe Harbor Fiduciary’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-69	Closed	-$506	–	258
2025 Q1	$506	Hold	69	–	–	﹤0.01%	203
2024 Q4	$1.77K	Hold	69	–	–	﹤0.01%	159
2024 Q3	$1.72K	Buy	+69	New	+$2.55K	﹤0.01%	172

Other funds holding SXTP

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Safe Harbor Fiduciary's SXTP Position: Q2 2025 in Review

Safe Harbor Fiduciary sold out of 60 Degrees Pharmaceuticals (SXTP) in Q2 2025, closing a stake of 69 shares — an estimated $506 sold.

Safe Harbor Fiduciary first reported a position in SXTP in Q3 2024 and held it in 3 quarters. The position peaked at $1.77K in Q4 2024. 5 funds tracked by Wall St. Rank hold SXTP as of Q2 2025.

Safe Harbor Fiduciary reported no remaining 60 Degrees Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Safe Harbor Fiduciary sold 69 60 Degrees Pharmaceuticals shares in Q2 2025, an estimated $506.
Safe Harbor Fiduciary first reported a position in 60 Degrees Pharmaceuticals in Q3 2024 and held it in 3 quarters.
Safe Harbor Fiduciary's 60 Degrees Pharmaceuticals position peaked at $1.77K in Q4 2024.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q2 2025.

Based on Safe Harbor Fiduciary's 13F filing for Q2 2025, filed 13 Aug 2025.